NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with neuromuscular diseases, announces that the US Food and Drug ...
MBR Genomics partners with Axio BioPharma to make MKLP1 Pro antibodies commercially available: Madison, Wisconsin Tuesday, January 7, 2025, 15:00 Hrs [IST] In a milestone for cel ...
Oculis Holding’s OCS-05 phase 2 ACUITY trial in acute optic neuritis meets primary safety endpoint and key secondary efficacy endpoints: Zug, Switzerland Tuesday, January 7, 202 ...
Biotech Showcase 2025 is set to convene in San Francisco for Biotech Investor Conference: Our Bureau, Mumbai Tuesday, January 7, 2025, 12:00 Hrs [IST] Biotech Showcase 2025, an ex ...
Claypond Capital appoints Dr Shravan Subramanyam to lead its medical technology platform: Our Bureau, Bengaluru Tuesday, January 7, 2025, 11:45 Hrs [IST] Claypond Capital, the fam ...
Our Bureau, Bengaluru Tuesday, January 7, 2025, 11:30 Hrs [IST] CRIUS Group has emerged as India’s first contract manufac ...
Sun Pharma inaugurates Training-Cum-Production Centre to empower women in Jammu: Our Bureau, Mumbai Tuesday, January 7, 2025, 11:15 Hrs [IST] As a part of its CSR vision to bring ...
Pratteln, Switzerland Tuesday, January 7, 2025, 11:00 Hrs [IST] ...
CHOP researchers develop new tool with potential to advance precision medicine treatment for cancer: Philadelphia, Pennsylvania Tuesday, January 7, 2025, 10:00 Hrs [IST] Researche ...
Astellas Pharma’s Vyloy receives China NMPA approval for first-line treatment of advanced gastric or GEJ adenocarcinoma: Tokyo Tuesday, January 7, 2025, 09:00 Hrs [IST] Astellas ...
Indian pharma notes revised Schedule M extension signals key step to avoid closure of units: Nandita Vijayasimha, Bengaluru Tuesday, January 7, 2025, 08:00 Hrs [IST] Indian pharma ...
CDSCO establishes Sub-Zonal Office in Bhubaneswar, boosting Odisha’s pharmaceutical sector: Shardul Nautiyal, Mumbai Tuesday, January 7, 2025, 08:00 Hrs [IST] In a significant m ...